Become a Member and get exclusive discounted Prices and Deals.

FoundationOne Liquid CDx Cancer Test

Foundation MedicineSKU: FM-CDX-L-I4-SD

FoundationOne Liquid CDx is an FDA-approved companion diagnostic that analyzes guideline-recommended genes from a simple blood draw. It is the only FDA-approved blood-based test to analyze over 300 genes.* Plus, it reports blood tumor mutational burden (bTMB), microsatellite instability (MSI), and tumor fraction values—making it the most comprehensive FDA-approved liquid biopsy on the market.

Full Description

With more targeted therapy options, comprehensive genomic profiling with FoundationOne Liquid CDx can help guide treatment strategies and help predict patient benefit across multiple cancer indications.

Customer Review